Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Santhera Pharmaceuticals (Sweden) AB
AB
Active
Org 5595156976
Other education n.e.c.
· NACE 8559
Est. 2025
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other education n.e.c.
/
Santhera Pharmaceuticals (Sweden) AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
AG
Aude Géraldine Lescure
External Signatory
External Signatory
2025
CJ
Charles Joseph Sininski
External Signatory
External Signatory
2025
OP
Oliver Philipp Kronenberg
External Signatory
External Signatory
2025
SE
Stina Elin Ulrika Wiström
Authorized Recipient of Service
Authorized Recipient of Service
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
CA
Catherine Ann Isted
Chairman
2025
AH
Andreas Hanno Missy
Board of Directors
2025
SE
Sarah Elizabeth Holmes-Klotz
Board of Directors
2025
OS
Oliver Strub
Board of Directors
2025
Former (15)
JA
Jan Anders Fredrik Lovén
Deputy Board Member
2025 – 2025
JT
Jan Totte Dahlin
Deputy Board Member
2025 – 2025
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2025 – 2025
EM
Emma Maria Birgitta Wik
Deputy Board Member
2025 – 2025
AH
Andreas Hans Eddie Ottosson
Deputy Board Member
2025 – 2025
LA
Lars Anders Larsson
Board of Directors
2025 – 2025
LM
Linn Mikaela Engman
Deputy Board Member
2025 – 2025
AS
Anna Stina Hammarström
Deputy Board Member
2025 – 2025
AM
Aline Madeleine Pettersson
Deputy Board Member
2025 – 2025
AC
Anna Carolina Maria Bjarnhagen
Deputy Board Member
2025 – 2025
EA
Elin Anna Margareta Spjut
Deputy Board Member
2025 – 2025
TA
Tuva Amalia Lundin
Deputy Board Member
2025 – 2025
JL
Jill Liv Maria Jonsson Wik
Deputy Board Member
2025 – 2025
JE
Julia Engla Eva M Arnfridsdotter
Deputy Board Member
2025 – 2025
AK
Anna Klara Alina Bruksås Nybjörk
Deputy Board Member
2025 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Santhera Pharmaceuticals (Sweden) AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot